Could common bone drug shield cancer patients from painful fractures?
NCT ID NCT07245381
Summary
This study is testing whether alendronate, a medication typically used for osteoporosis, can help prevent pelvic fractures in cervical cancer patients undergoing chemotherapy and radiation. Researchers will enroll 65 patients to see if the drug strengthens bones and reduces fracture risk while monitoring side effects and quality of life. The goal is to find a way to protect patients from this painful complication of cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVIX CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.